DnB Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-243,050
Closed -$1.93M 772
2025
Q1
$1.93M Buy
+243,050
New +$2.46M 0.01% 578
2022
Q4
Sell
-112,901
Closed -$2.86M 653
2022
Q3
$2.86M Buy
112,901
+60,581
+116% +$2.13M 0.02% 434
2022
Q2
$1.74M Buy
52,320
+29,395
+128% +$1.25M 0.01% 536
2022
Q1
$1.65M Sell
22,925
-37,114
-62% -$2.67M 0.01% 567
2021
Q4
$5.51M Buy
60,039
+40,676
+210% +$4.86M 0.03% 348
2021
Q3
$2.46M Buy
19,363
+510
+3% +$74.3K 0.02% 503
2021
Q2
$3.14M Buy
18,853
+3,055
+19% +$495K 0.02% 456
2021
Q1
$2.87M Buy
15,798
+1,415
+10% +$328K 0.02% 460
2020
Q4
$2.88M Buy
+14,383
New +$2.92M 0.03% 385
2020
Q3
Sell
-10,340
Closed -$1.97M 619
2020
Q2
$1.97M Buy
+10,340
New +$1.81M 0.02% 390

Other funds holding TDOC

DnB Asset Management's TDOC Position: Q2 2025 in Review

DnB Asset Management sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 243,050 shares — an estimated $1.93M sold.

DnB Asset Management first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $5.51M in Q4 2021. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • DnB Asset Management reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • DnB Asset Management sold 243,050 Teladoc Health shares in Q2 2025, an estimated $1.93M.
  • DnB Asset Management first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • DnB Asset Management's Teladoc Health position peaked at $5.51M in Q4 2021.
  • 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on DnB Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.